OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Treatment of Metastatic Colorectal Cancer

home / peer-exchange / crc-therapies
TRIBE Trial: First-Line Treatment of mCRC

EP. 1: TRIBE Trial: First-Line Treatment of mCRC

September 29th 2013
PRIME Trial: RAS Mutations in Metastatic Colorectal Cancer

EP. 2: PRIME Trial: RAS Mutations in Metastatic Colorectal Cancer

September 29th 2013
EPOC Studies: Preoperative Treatments in CRC

EP. 3: EPOC Studies: Preoperative Treatments in CRC

September 29th 2013
FIRE-3 Study: Cetuximab Versus Bevacizumab in mCRC

EP. 4: FIRE-3 Study: Cetuximab Versus Bevacizumab in mCRC

September 29th 2013
Predictive Value of RAS Mutations in mCRC

EP. 5: Predictive Value of RAS Mutations in mCRC

September 29th 2013
Case Study: Borderline Resectable mCRC

EP. 6: Case Study: Borderline Resectable mCRC

September 29th 2013
Maintenance Therapy in Metastatic Colorectal Cancer

EP. 7: Maintenance Therapy in Metastatic Colorectal Cancer

September 29th 2013
Antiangiogenic Therapy in Metastatic Colorectal Cancer

EP. 8: Antiangiogenic Therapy in Metastatic Colorectal Cancer

September 29th 2013
Second-Line and Salvage Treatment of mCRC

EP. 9: Second-Line and Salvage Treatment of mCRC

September 29th 2013
Novel Therapies in Development for mCRC

EP. 10: Novel Therapies in Development for mCRC

September 29th 2013
Personalized Medicine in Colorectal Cancer

EP. 11: Personalized Medicine in Colorectal Cancer

September 29th 2013

Latest Conference Coverage

GI Cancer Experts on Notable Updates Shared During the 2025 ASCO Annual Meeting

Hematologists Highlight Notable Insights From the 2025 EHA Congress

Post Hoc Analysis Shows Imetelstat Drives Benefit in RS-Negative, Lower-Risk MDS

Bexobrutideg Is Tolerable and Yields High Response Rates in Relapsed/Refractory Waldenström Macroglobulinemia

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact